Valachis A - Search Results

1

Comprehensive Genome Profiling for Treatment Decisions in Patients with Metastatic Tumors: Real-World Evidence Meta-Analysis and Registry Data Implementation.

Zerdes I, Filis P, Fountoukidis G, El-Naggar AI, Kalofonou F, D'Alessio A, Pouptsis A, Foukakis T, Pentheroudakis G, Ahlgren J, Smith D, Valachis A. Zerdes I, et al. Among authors: valachis a. J Natl Cancer Inst. 2025 Jan 22:djaf015. doi: 10.1093/jnci/djaf015. Online ahead of print. J Natl Cancer Inst. 2025. PMID: 39842854

2

Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting.

Olsson E, Lindman H, Digkas E, Thurfjell V, Ali HM, Krüger U, Wennstig AK, Sundqvist M, Valachis A. Olsson E, et al. Among authors: valachis a. Breast. 2025 Jan 2;79:103874. doi: 10.1016/j.breast.2025.103874. Online ahead of print. Breast. 2025. PMID: 39778370 Free article.

3

Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer.

Palmér S, Valachis A, Lindman H, Smith DR, Wickberg Å, Killander F, Bjöhle J, Einbeigi Z, Nilsson G, Ahlgren J, Villman K. Palmér S, et al. Among authors: valachis a. J Natl Cancer Inst. 2024 Dec 4:djae315. doi: 10.1093/jnci/djae315. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39656805

4

Biochemical outcome of prostate cancer patients treated with hypofractionated external radiation and a single high-dose-rate brachytherapy boost.

Staby Olsén J, Valachis A, PhLic LK, Johansson B. Staby Olsén J, et al. Among authors: valachis a. Brachytherapy. 2025 Jan-Feb;24(1):45-53. doi: 10.1016/j.brachy.2024.07.005. Epub 2024 Nov 22. Brachytherapy. 2025. PMID: 39578204 Free article.

5

Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer.

Ladjevardi CO, Skribek M, Koliadi A, Rydén V, El-Naggar AI, Digkas E, Valachis A, Ullenhag GJ. Ladjevardi CO, et al. Among authors: valachis a. Cancer Immunol Immunother. 2024 Nov 7;74(1):14. doi: 10.1007/s00262-024-03869-1. Cancer Immunol Immunother. 2024. PMID: 39508883 Free PMC article.

6

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients.

Valachis A, Biganzoli L, Christopoulou A, Fjermeros K, Fountzila E, Geisler J, Gomez-Bravo R, Karihtala P, Kosmidis P, Koutras A, Linardou H, Lindman H, Martínez-Ballestero I, Rodríguez AB, Meattini I, Munoz-Mateu M, Othman M, Psyrri A, Risi E, Schiza A, Spathas N, Utriainen M, Visani L, Ballesteros S, Basdekis I, Hay SD, Fotis T, Fricker S, de Graaf G, Jenset M, Kanters T, Lampropoulos K, Markou C, Mastoraki K, Nanou C, Reales Aviles JM, Santaholma M, Kosmidis T. Valachis A, et al. Future Oncol. 2024;20(37):2937-2948. doi: 10.1080/14796694.2024.2413841. Epub 2024 Oct 21. Future Oncol. 2024. PMID: 39431459 Free PMC article. Clinical Trial.

7

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer.

Bardia A, Hu X, Dent R, Yonemori K, Barrios CH, O'Shaughnessy JA, Wildiers H, Pierga JY, Zhang Q, Saura C, Biganzoli L, Sohn J, Im SA, Lévy C, Jacot W, Begbie N, Ke J, Patel G, Curigliano G; DESTINY-Breast06 Trial Investigators. Bardia A, et al. N Engl J Med. 2024 Dec 5;391(22):2110-2122. doi: 10.1056/NEJMoa2407086. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282896 Clinical Trial.

8

Moderately hypofractionated prostate-only versus whole-pelvis radiotherapy for high-risk prostate cancer: A retrospective real-world single-center cohort study.

Kahlmeter Brandell J, Valachis A, Ugge H, Smith D, Johansson B. Kahlmeter Brandell J, et al. Among authors: valachis a. Clin Transl Radiat Oncol. 2024 Aug 21;48:100846. doi: 10.1016/j.ctro.2024.100846. eCollection 2024 Sep. Clin Transl Radiat Oncol. 2024. PMID: 39258243 Free PMC article.

9

Lessons learned from an unsuccessful decentralized clinical trial in Oncology.

Valachis A, Lindman H. Valachis A, et al. NPJ Digit Med. 2024 Aug 13;7(1):211. doi: 10.1038/s41746-024-01214-5. NPJ Digit Med. 2024. PMID: 39138304 Free PMC article.

10

Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness.

Olsson Ladjevardi C, Koliadi A, Rydén V, El-Naggar AI, Digkas E, Valachis A, Ullenhag GJ. Olsson Ladjevardi C, et al. Among authors: valachis a. Front Oncol. 2024 Jun 26;14:1399171. doi: 10.3389/fonc.2024.1399171. eCollection 2024. Front Oncol. 2024. PMID: 38988708 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters